Generic Medicine Pharma
Azarest (Olaparib) 300mg
Azarest (Olaparib) 300mg
Azarest 300mg contains Olaparib, a targeted anticancer medicine used to treat cancers associated with BRCA gene mutations, including ovarian, breast, pancreatic, and prostate cancers. Olaparib works by inhibiting PARP enzymes involved in DNA repair, leading to cancer cell death and slowing tumor progression.
| Field | Details |
|---|---|
| Original Brand | Lynparza |
| Generic Brand | Azarest 300 |
| Generic Name | Olaparib 300mg |
| Pack Size | 56 Tablets |
| Use / Indications | Ovarian Cancer, Breast Cancer, Pancreatic Cancer, Prostate Cancer |
| Manufacturer | Everest Pharmaceuticals Ltd. (Produced in Bangladesh) |
| Status | Prescription Only Medicine |
Introduction to Lynparza (Olaparib) 300mg
Lynparza (Olaparib) 300mg is a prescription medicine used in the treatment of several types of cancer, particularly ovarian cancer, breast cancer, pancreatic cancer, and prostate cancer associated with BRCA gene mutations. This medicine belongs to a specialized group of targeted oncology drugs that work by interfering with cancer cell DNA repair mechanisms.
Lynparza (Olaparib) 300mg is classified under Prescription Medicines, Oncology Medicines, Anticancer Drugs, and Targeted Cancer Therapies. It contains Olaparib, which works by blocking enzymes responsible for repairing damaged DNA in cancer cells.
In some markets, Azarest 300mg is available as a generic brand containing the same active ingredient Olaparib, offering a similar therapeutic effect when prescribed by a qualified healthcare professional.
What Is Lynparza (Olaparib)?
Lynparza is the original brand name for Olaparib, an oral medication widely used for the treatment of cancers associated with BRCA gene mutations and defects in DNA repair pathways.
Olaparib belongs to a class of medicines known as PARP inhibitors (Poly ADP-ribose polymerase inhibitors). These medicines prevent cancer cells from repairing their DNA, leading to cancer cell death.
Generic versions such as Azarest 300mg contain the same active compound and may be used depending on physician recommendation and regional availability.
Drug Class and Mechanism of Action
Olaparib is classified as a PARP inhibitor with strong antineoplastic activity used in targeted cancer therapy.
How Olaparib Works
It works in several ways:
- Inhibits PARP enzymes involved in DNA repair
- Prevents cancer cells from fixing damaged DNA
- Causes accumulation of DNA damage leading to cancer cell death
Through these mechanisms, Olaparib helps slow or stop the growth of certain cancers.
How Lynparza Works in the Body
Cancer cells with BRCA mutations rely heavily on PARP enzymes to repair DNA damage. Lynparza blocks this repair pathway.
Key Actions of Olaparib
- Blocks PARP-mediated DNA repair processes
- Increases DNA damage inside cancer cells
- Promotes cancer cell death through synthetic lethality
Some generic versions such as Azarest deliver the same active compound, allowing similar targeted cancer therapy when prescribed appropriately.
Medical Uses of Lynparza (Olaparib) 300mg
Lynparza 300mg is widely prescribed for several cancers associated with defective DNA repair pathways.
Lynparza for Ovarian Cancer
For patients with BRCA mutation-positive ovarian cancer, Lynparza is commonly used as maintenance therapy after chemotherapy.
Potential Benefits
- Helps delay cancer progression
- Extends progression-free survival
- Reduces recurrence risk in some patients
Generic alternatives like Azarest 300mg may also be used under medical supervision when Olaparib therapy is recommended.
Lynparza for Breast Cancer
Olaparib is also used for HER2-negative breast cancer associated with BRCA mutations.
Treatment Benefits
- Targets cancer cells with defective DNA repair mechanisms
- Helps slow tumor growth
- Supports personalized cancer treatment strategies
Lynparza for Prostate and Pancreatic Cancer
Lynparza may also be prescribed for certain metastatic prostate cancers and pancreatic cancers with BRCA or homologous recombination repair gene mutations.
Potential Benefits
- Precision treatment targeting genetic mutations
- May improve progression-free survival
- Offers targeted therapy option after prior treatments
Who Can Take Azarest 300mg?
Because Olaparib is a potent targeted therapy medicine, treatment should always be supervised by an experienced healthcare provider.
Eligibility Criteria
Patients may be prescribed Lynparza if they:
- Have BRCA mutation-positive cancers
- Are diagnosed with ovarian, breast, pancreatic, or prostate cancer
- Have completed prior chemotherapy or other cancer treatments
Certain generic options such as Azarest may also be considered depending on availability and physician decision.
Who Should Avoid Lynparza (Olaparib) 300mg
Lynparza should NOT be used by:
- Pregnant women or women planning pregnancy
- Individuals with hypersensitivity to Olaparib
- Patients with severe bone marrow suppression unless monitored by a specialist
Lynparza (Olaparib) 300mg Dosage and Administration
Standard Dosage Guidelines
Typical dosage recommendations include:
- Lynparza 300mg twice daily
- Tablets should be swallowed whole with water
- Can be taken with or without food
- Treatment continues as long as clinical benefit is observed
Dosage Adjustments
Doctors may adjust the dose depending on:
- Kidney function
- Blood test results such as anemia or neutropenia
- Individual treatment response and side effects
Side Effects of Lynparza 300mg
Like all cancer medicines, Lynparza may cause side effects.
Common Side Effects
- Nausea or vomiting
- Fatigue and weakness
- Anemia (low red blood cell count)
- Loss of appetite
Serious Side Effects
Bone Marrow Suppression: Low blood cell counts
Myelodysplastic Syndrome (MDS): Rare but serious bone marrow disorder
Pneumonitis: Rare lung inflammation
Patients should report any unusual symptoms to their doctor immediately.
Storage:
Store below 25°C in a cool, dry place, protected from moisture and direct sunlight. Keep the tablets in their original packaging and out of reach of children.
Frequently Asked Questions (FAQs)
1. What is Lynparza (Olaparib) 300mg used for?
Lynparza is used to treat certain cancers with BRCA gene mutations, including ovarian, breast, pancreatic, and prostate cancers.
2. Is Olaparib chemotherapy?
No. Olaparib is a targeted therapy known as a PARP inhibitor that specifically targets cancer cell DNA repair mechanisms.
3. How is BRCA mutation detected?
Doctors use genetic or molecular testing on blood or tumor samples to detect BRCA mutations.
4. Can Lynparza cure cancer?
Lynparza does not cure cancer but helps slow tumor growth and delay disease progression in eligible patients.
5. Is Azarest 300mg the same as Lynparza?
Azarest 300mg contains Olaparib, the same active ingredient found in Lynparza. Generic versions is available. for more info. contact on WhatsApp: https://wa.me/8801742433764
6. Do I need a prescription to buy Azarest (Olaparib) 300mg?
Yes. Azarest 300mg is a prescription-only medicine and should only be used under the supervision of a qualified healthcare professional.
Medical Disclaimer
Disclaimer:
The information provided on this page is for educational and informational purposes only and should not be considered medical advice. Lynparza (Olaparib) is a prescription-only medication and must be used strictly under the supervision of a qualified healthcare professional. Always consult your physician before starting, stopping, or changing any medication.





